Coronavirus Could Be Defeated By Cell Therapy Created By Dolly The Sheep Scientists


Treatment for the deadly Covid-19 infection using immune cells from young and healthy volunteers may be available at the NHS in a few weeks, it was reported.

Scientists responsible for the cloning of Dolly the Sheep in 1996 are said to be in talks with the government to use the new therapy.

He has previously used transfusions of immune-boosting cells to successfully treat cancer. Now scientists believe it will also work against the coronavirus.

“One of the main challenges in fighting viral infection is to develop something that will attack infected cells, not normal cells,” said Dr. Brian Kelly, senior strategic medical advisor in the study, at Telegraph.

Do you have a coronavirus story to share? Email [email protected]

Driving test station established at Chessington World of Adventures in Greater London

“So the solution we found was to look at the body’s natural defenses against viral infection.

“In patients who have successfully fought a viral infection, they have developed their own immune systems and this persists to keep them from becoming infected again. “

Dr. Kelly leads a group of researchers at TC BioPharm, a cell therapy company near Glasgow. It was founded by Angela Scott, who was part of the team that cloned Dolly the Sheep in Edinburgh in 1996.

Read more

Changes to the Coronavirus supermarket

But Dr. Kelly said that the latest treatment saw donor T cells differ from normal immune cells because they did not identify invaders in the body based on exotic protrusions on the surface of the cells, but by detecting the unusual metabolism of the cells. virus.

When donor cells detect a virus, they begin to destroy it while signaling it to the rest of the immune system as a foreign intrusion requiring eradication.

Dr. Kelly said that with this approach, even if the virus mutated and returned to a body, the infusion exercise could be repeated and would still work.


Please enter your comment!
Please enter your name here